| Quarter | Prior | Estimate | Actual | Surprise | |
|---|---|---|---|---|---|
| Q4 2021 After-Hours | EPS: REV: | ||||
| Q3 2021 After-Hours | EPS: REV: | -1.34 3.835M | |||
| Q2 2021 After-Hours | EPS: REV: | ||||
| Q1 2021 After-Hours | EPS: REV: | -1.15 58K | |||
| Q4 2020 After-Hours | EPS: REV: | -0.99 89K | -1.24 8.78M | -1.24 11.133M | 0% 26.8% |
| Q3 2020 After-Hours | EPS: REV: | -0.96 46K | -1.03 1.78M | -1.34 3.835M | -30.1% 115.45% |
| Q2 2020 After-Hours | EPS: REV: | -0.86 0 | -1.01 450K | -1.12 299K | -10.89% -33.56% |
| Q1 2020 After-Hours | EPS: REV: | -0.85 278K | -0.90 170K | -1.15 58K | -27.78% -65.88% |
| Q4 2019 After-Hours | EPS: REV: | -1.12 487K | -0.98 2.29M | -0.99 89K | -1.02% -96.11% |
| Q3 2019 After-Hours | EPS: REV: | -0.91 2.362M | -0.98 430K | -0.96 46K | 2.04% -89.3% |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- A Peek Into The Markets: US Stock Futures Edge Lower Following Monday's Rally; Crude Oil Drops 1%
- 5 Stocks To Watch For March 2, 2021
- Earnings Scheduled For March 2, 2021
- DraftKings Analysts Cheer Strong Q4, Sports Betting Growth And SBTech Integration
- Nio Reports Wider Q4 Loss Despite Revenues Topping $1B
- Travere Therapeutics: Q4 Earnings Insights
- Arcturus Therapeutics: Q4 Earnings Insights
- Hanger: Q4 Earnings Insights
- Recap: Xenon Pharmaceuticals Q4 Earnings
- Helios Technologies: Q4 Earnings Insights
